Corbus Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
- Company focused on gaining regulatory clarity for late-stage lenabasum program and advancing programs targeting the endocannabinoid system and integrins into the clinic
- Augmentingthe pipeline through business development continues to be a priority
- Cash…
